Kennedy Capital Management, Inc. Myriad Genetics Inc Transaction History

Kennedy Capital Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$19.92 - $31.6 $515,609 - $817,934	-25,884 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$12.16 - $19.77 $314,749 - $511,726	25,884 New	25,884 $512,000
Q1 2020 May 15, 2020	SELL	$9.78 - $29.53 $960,826 - $2.9 Million	-98,244 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$20.93 - $35.1 $2.06 Million - $3.45 Million	98,244 New	98,244 $2.68 Million
Q1 2019 May 13, 2019	SELL	$26.93 - $34.7 $10.2 Million - $13.2 Million	-380,075 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$27.23 - $45.56 $10.3 Million - $17.3 Million	380,075 New	380,075 $11 Million

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.25B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.